Roy Dennis Bloom

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
One Founders Pavilion
3400 Spruce Street
Philadelphia, Pa 19104-6144
Office: (215) 662-4643
Fax: (215) 615-0349
Education:
BSc (Physiology and Biochemistry)
University of Witwatersrand, 1980.
M.B.B.Ch.
University of Witwatersrand, 1983.
Permanent link
 

Description of Research Expertise

Kidney transplant outcomes, Post-transplant diabetes mellitus, hepatitis C in kidney transplantation

Description of Itmat Expertise

Dr. Bloom engages in clinical outcomes research, particularly pertaining to hepatitis C, transplant associated hyperglycemia and combined liver-kidney transplantation. He also has an active interest in immunosuppressive drug trials, both investigator-initiated and biopharmaceutical-initiated multicenter studies.

Selected Publications

Harhay MN, Hill AS, Wang W, Even-Shoshan O, Mussell AS, Bloom RD, Feldman HI, Karlawish JH, Silber JH, Reese PP. : Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation. PLoS One 11(6): e0156532, June 2016.

Sawinski D, Kaur N, Ajeti A, Trofe-Clark J, Lim M, Bleicher M, Goral S, Forde KA and Bloom RD. : Successful treatment of Hepatitis C in renal transplant recipients with direct-acting antiviral agents. American Journal of Transplantation 16((5)): 1588-95, May 2016.

Lim MA, Kohli J, Bloom RD: Immunosuppression for Kidney Transplantation: Where are we now and where are we going? Transplantation Reviews (in press), 2016.

Cohen JB, Bloom RD, Reese PP, Porrett PM, Forde KM, Sawinski DL.: National Outcomes of Kidney Transplantation from Deceased Diabetic Donors. Kidney International (in press) 2016.

Choudhury RA, Reese PP, Goldberg DS, Bloom RD, Sawinski DL, Abt PL: A Paired Kidney Analysis of Multiorgan Transplantation: Implications for Allograft Survival. Transplantation (in press) 2016.

Sawinski D, Bloom RD: Novel Hepatitis C Treatment and the Impact on Kidney Transplantation. Transplantation 99(12): 2458-66, December 2015.

Reese PR, Shults J, Bloom RD, Mussell A, Harhay MN, Abt P, Levine M, Johansen KL, Karlawish JT, Feldman HI: Functional status, time to transplant, and survival benefit of kidney transplantation among wait-listed candidates. American Journal of Kidney Diseases 66(5): 837-45, November 2015.

Sawinski D, Forde KA, Eddinger K, Troxel AB, Blumberg E, Tebas P, Abt PL, Bloom RD: Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients. Kidney International 88(2): 341-9, August 2015.

Richterman A, Sawinski D, Reese PP, Lee DH, Clauss H, Hasz RD, Thomasson A, Goldberg D, Abt PL, Forde KA, Bloom RD, Doll S, Brady KA, Blumberg E: An Assessment of HIV-Infected Patients Dying in Care for Deceased Organ Donation in a United States Urban Center American Journal of Transplantation 15(8): 2105-16, August 2015.

Sawinski D, Goldberg DS, Blumberg E, Abt PL, Bloom RD, Forde KA. : Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States Clinical Infectious Diseases (in press), June 2015.

back to top
Last updated: 06/05/2016
The Trustees of the University of Pennsylvania